# Progress Note 04 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Phillis Wheatley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN015-SYN-TD
- Date: 1773-04-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Abena Hartley-Okonkwo, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning), CPT 90651 (HPV vaccine), CPT 90739 (hepatitis B vaccine) and CPT 90471 and 90472 (vaccine administration), all on the same day

## Chief complaint

Preventive visit before a long sea journey; asthma well controlled. **S**

## History of present illness

Miss Wheatley, 19, comes for her preventive visit three weeks after her asthma review and about ten days before she sails abroad, where she expects to spend the summer while her book is printed. Her asthma is well controlled on as-needed budesonide-formoterol: she uses one inhalation about twice a week, has not woken at night for two months, and her peak flow stays between 360 and 400 L/min. She carries her action plan, her standby prednisone and her seasickness tablets. She asked for time to talk about contraception and about what asthma would mean in a future pregnancy, and was seen alone for the whole visit. **S**

| Element | Detail |
|---|---|
| Visit | Periodic preventive visit, age 19 |
| Active conditions | Asthma, mild persistent, well controlled on GINA track 1 step 2 |
| Medicines | Budesonide-formoterol as needed; standby prednisone and meclizine for the journey |
| Upcoming | A long sea crossing and a summer away from her clinic |

## Health risk assessment

Completed by the patient on paper in a private room and reviewed with her alone by Dr. Hartley-Okonkwo. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and better than in the winter |
| Psychosocial | Her faith, her writing and a close friend she writes to; lives in the household described in her social history; hopes for her freedom |
| Tobacco and exposures | Never smoked or vaped; now opens a window and uses the kitchen fan when cooking |
| Alcohol and drugs | None (AUDIT-C 0) |
| Physical activity | Walks most days; no longer stops on the hills |
| Nutrition | Three small meals; dairy most days; no restriction or bingeing |
| Sleep | Six to seven hours; writes late at night |
| Sexual and reproductive health | Not sexually active; regular periods; no pregnancy now; she may wish to marry and have children one day |
| Safety | Not hit, hurt or threatened; does not hold her own papers or wages (see social history); no firearm in the house |
| Road and travel safety | Wears a seat belt; travel insurance and a copy of her medical summary arranged for the journey |
| Activities of daily living | Independent |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight up 1 kg since the winter; energy good |
| Eyes | Negative | Reads for hours without strain; no vision change |
| Ears, nose, mouth, and throat | Negative | No hoarseness, thrush or nasal blockage |
| Respiratory | Negative | No night waking; reliever about twice a week |
| Cardiovascular | Negative | No chest pain or palpitations |
| Gastrointestinal | Negative | No heartburn or bowel change |
| Genitourinary | Negative | Regular periods every 28 to 30 days; no heavy bleeding or pain |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No rash |
| Neurological | Negative | No headaches |
| Psychiatric | Negative | Mood steady; some worry about the journey; PHQ-9 4, GAD-7 3 |

11 systems reviewed. **S**

## Current medications

- Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a day **S**
- Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs **S**
- Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasickness **S**
- Folic acid 0.4 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 102/64 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 46.6 kg; BMI 20.2 kg/m². All vital signs are synthetic.

PHQ-9: 4; GAD-7: 3. All results are synthetic.

## Immunizations given today

- Human papillomavirus vaccine (9-valent), dose 1 of 3 **S**
- Hepatitis B vaccine (HepB-CpG), dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Slight and well; weight 46.6 kg, BMI 20.2; blood pressure 102/64, pulse 74 |
| Head, eyes, ears, nose, and throat | No oral thrush; nasal mucosa normal; teeth and gums healthy |
| Neck | Thyroid not enlarged; no lymph nodes |
| Respiratory | Clear on forced expiration |
| Cardiovascular | Regular rhythm; no murmur |
| Integumentary | No rash |
| Psychiatric | Warm, thoughtful and engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic preventive visit completed**. Health risk assessment reviewed and a written prevention plan given. Depression and anxiety screens are minimal; no safety concern needing urgent action. **S**
   - Next preventive visit in one year.
2. **Asthma, well controlled** (J45.30). Controlled on as-needed budesonide-formoterol; ready for the journey. **S**
   - Travel plan from the six-week review confirmed.
3. **Contraception and pregnancy planning**. Not sexually active and does not want contraception now. Every method, including the implant, intrauterine devices and combined pills, is suitable for a woman with asthma (U.S. Medical Eligibility Criteria). If she becomes pregnant, well-controlled asthma is safe for her and the baby; uncontrolled asthma is the greater risk. Budesonide is the inhaled steroid with the most reassuring pregnancy data, and her controller should never be stopped because of a pregnancy. **S**
   - Folic acid 0.4 mg daily, by her choice.
   - Information on emergency contraception and on each method, to take with her.
   - Plan any pregnancy with the clinic: asthma review and spirometry before and during pregnancy.
4. **Screening tests for a woman born in West Africa**. Hepatitis B screening is recommended for people born where hepatitis B is common; HIV and hepatitis C once in adulthood; tuberculosis infection test already negative. **S**
   - Hepatitis B surface antigen, surface antibody and core antibody, HIV and hepatitis C antibody drawn today; results to her own phone.
   - Hepatitis B and HPV vaccine series started today.

## Medication changes

- Started: Folic acid 0.4 mg oral tablet, one tablet daily **S**

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 102/64 mmHg |
| Depression screening | Completed today | PHQ-9 score 4; item 9 scored 0 |
| Anxiety screening | Completed today | GAD-7 score 3 |
| Unhealthy alcohol and drug use screening | Completed today | None |
| Intimate partner violence and exploitation screening | Completed today | Asked privately; no violence; the domestic servitude in her social history is known, and resources and social work have been offered and her choices respected |
| Contraception and pregnancy planning | Completed today | Counselled; no method wanted now; asthma in pregnancy discussed |
| Folic acid | Completed today | 0.4 mg daily started, by her choice |
| Hepatitis B screening | Ordered | Born in a region where hepatitis B is common; antigen and antibodies drawn today |
| HIV and hepatitis C screening | Ordered | Once-in-adulthood tests drawn today with her agreement |
| Latent tuberculosis infection screening | Up to date | Interferon-gamma release assay negative at intake |
| Chlamydia and gonorrhea screening | Not indicated | Not sexually active; to be offered if that changes |
| Cervical cancer screening | Not indicated | Begins at 21 |
| HPV vaccine | Completed today | Dose 1 of 3 (series started after 15) |
| Hepatitis B vaccine | Completed today | HepB-CpG dose 1 of 2; dose 2 due in a month, after she returns |
| Pneumococcal vaccine | Up to date | PCV20 two months ago (asthma is an indication from 19) |
| Influenza and COVID-19 vaccines | Up to date | Given this season two months ago; due again in the autumn |
| Tetanus, diphtheria, and pertussis | Up to date | Tdap at 12 on her school record, which also shows two doses each of MMR and varicella, polio and two MenACWY doses |
| Travel health | Completed today | No vaccines beyond the routine schedule are needed for the crossing and the summer in England; seasickness advice; insurance and a medical summary |

## Advance care planning

Voluntary advance care planning discussion of about 16 minutes, with her consent. She chose to name a health care agent, a person she trusts outside the household, recorded in the confidential part of the chart and not named here, because she wants decisions about her care made by someone of her own choosing if she were ever unable to speak for herself, including while she is abroad. She wants full treatment for any illness she could recover from. She chose not to record other preferences today; to be revisited at any change in her health or circumstances. **S**

## Guideline basis

- Global Strategy for Asthma Management and Prevention, 2025 update (2025), Global Initiative for Asthma
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (2024), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- ACOG Practice Bulletin No. 90: Asthma in Pregnancy. Obstet Gynecol 2008;111(2 Pt 1):457-464 (PMID 18238988) (2008), American College of Obstetricians and Gynecologists

## Follow-up

- Results to her own phone. Hepatitis B and HPV doses after she returns. Asthma review on her return in the autumn, or sooner by message from abroad. Next preventive visit in one year. **S**
- Next scheduled visit 1773-10-26: asthma review after an exacerbation with a cold on her return from abroad: control, repeat spirometry and FeNO, the winter plan, completion of vaccines, and her changed circumstances. **S**
